Wolters Kluwer Health Expert to Explore the Critical Role of Analytics in Successful ICD-10 Transitions during HIMSS14
MINNEAPOLIS--(BUSINESS WIRE)--Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Brian Levy, M.D., its Vice President of Global Clinical Operations, Health Language, will share with HIMSS14 attendees his expert insights on the critical role data analytics plays in effective transitions to ICD-10. The session, Leveraging Analytics to Capture the Full Benefit of ICD-10, will take place at 11:30 a.m. EST on February 26 in Room 304A of the Orange County Convention Center in Orlando, FL.
“The impact of the industry’s move to the greatly expanded and highly granular ICD-10 code set is expected to be unprecedented. Time is running short for healthcare provider and payer organizations that have yet to finalize their transition planning”
The healthcare industry is running the last mile of its race toward the October 1 ICD-10 transition deadline. Dr. Levy, a practicing board-certified internist and nationally recognized healthcare informatics expert, will explore how organizations can accelerate readiness by leveraging analytics to proactively identify risk points and design strategies that improve documentation accuracy and revenue capture for the long-term.
Dr. Levy will analyze the full impact of the ICD-10 conversion on healthcare organizations and share with attendees the process for applying analytics to real-life use cases of existing claims data to identify areas of weakness and opportunity. Attendees will also learn how to design strategies to address identified financial risk points through clinical documentation improvement, streamlined conversion and improved billing. Finally, strategies for measuring the impact of analytics on documentation practices and revenue capture will be shared.
“The impact of the industry’s move to the greatly expanded and highly granular ICD-10 code set is expected to be unprecedented. Time is running short for healthcare provider and payer organizations that have yet to finalize their transition planning,” said Arvind Subramanian, President and CEO, Wolters Kluwer Health, Clinical Solutions. “Readiness strategies that leverage advanced data analytics such as those advocated by Dr. Levy enable healthcare organizations to be proactive in their approach, setting the stage for long-term success.”
To learn more about Wolters Kluwer Health, please visit Booth #1346 during HIMSS14.
About Wolters Kluwer Health
Wolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries and territories worldwide, Wolters Kluwer Health’s customers include professionals, institutions and students in medicine, nursing, allied health and pharmacy. Major brands include Health Language®, Lexicomp®, Lippincott Williams & Wilkins, Medicom®, Medknow, Ovid®, Pharmacy OneSource®, ProVation® Medical and UpToDate®.
Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Wolters Kluwer had 2012 annual revenues of €3.6 billion ($4.6 billion), employs approximately 19,000 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Follow our official Twitter handle: @WKHealth.